Therapeutic challenges using lomitapide in patients with homozygous familial hypercholesterolemia in middle-income countries: analysis of three real-world cases.

30 August 2026 (11:21 - 11:33)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Mr Daniel Felipe Ceron Caicedo

Cali (Colombia)

4 More presentations in this session

Presentation thumbnail

Sitosterolemia as a phenocopy of homozygous familial hypercholesterolaemia: a diagnostic challenge

Doctor V. Silva (Sao Paulo, BR)

Presentation thumbnail

Severe left ventricular outflow tract obstruction due to supravalvular aortic stenosis associated with homozygous familial hypercholesterolaemia in a young patient

Ms M. Bruni Ratto De Lima (Sao Paulo, BR)

Presentation thumbnail

Cholesterol-independent coronary disease progression revealed by electronegative LDL and HDL subfractions despite optimal guideline-directed lipid therapy

Doctor Y. Wang (Taichung, TW)

Presentation thumbnail

Chylomicronemia associated with APOA5 variants: report of two unrelated cases in Colombia with refractory severe hypertriglyceridemia.

Access the full session

Session thumbnail

Risk, reduction, and results: lipid cases in focus

The Event

Event poster

ESC Congress 2026

30 August 2026 11:21 CET

You may be interested in

Congress Presentation

Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population

3 April 2025

Congress Presentation

Sitosterolemia progressing to advanced heart failure

30 August 2025

Congress Session

Multi-disciplinary approaches to lipid management

24 June 2023

Webinar

How to treat patients with borderline dyslipidemia

8 February 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources